Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis
Cancer Medicine · 2023
DOI: 10.1002/cam4.6407 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2023. Verfasst von Sooin Byeon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Tumor Microenvironment, Carcinoma, Pancreatic Ductal, Single-Cell Analysis, Pancreatic Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies in the world, for which the mortality is almost as high as the disease incidence and is predicted to be the second‐highest cause of cancer‐related deaths by 2030. These cancerous tumors consist of diversified gene expressions within the different cellular subpopulations that include neoplastic ductal cells, cancer‐associated fibroblasts, and immune cells, all of which collectively facilitate cellular heterogeneity in the PDAC tumor microenvironment (TME). Active intratumoral interaction within the cell populations in TME induces the proliferation of cancerous cells, accounting for tumorigenesis and rapid metastasis.
Methods
This review will focus on novel findings uncovering PDAC heterogeneity in different cellular subpopulations using single‐cell RNA‐sequencing (scRNA‐seq) and other single‐cell analysis technologies. It will further explore the emerging role of single‐cell technologies in assessing the role of different subpopulations of neoplastic ductal cells, cancer‐associated fibroblasts, and immune cells in PDAC progression. Results and Conclusion The application of scRNA‐seq in PDAC has started to unveil associations between disease progression and heterogeneity in pancreatic TME and could influence future PDAC treatment. Recent advances in scRNA‐seq have uncovered comprehensive analyses of heterogeneous ecosystems present within the TME. These emerging findings underpins further need for a more in‐depth understanding of intratumoral heterogeneity in the PDAC microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
- Kolling Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
- Australian Pancreatic Centre, Sydney, New South Wales, Australia.
- Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia.
- NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
- Upper GI Surgical Unit, Royal North Shore Hospital and North Shore Private Hospital, St Leonards, New South Wales, Australia.
ORCID-Profile: Sumit Sahni
Zitieren
APA
Byeon, S., du Toit-Thompson, T., Gillson, J., Gill, A. J., Samra, J. S., Mittal, A., & Sahni, S. (2023). Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis. Cancer Medicine. https://doi.org/10.1002/cam4.6407
Vancouver
Byeon S, du Toit-Thompson T, Gillson J, Gill AJ, Samra JS, Mittal A, et al. Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis. Cancer Medicine. 2023. doi:10.1002/cam4.6407
BibTeX
@article{Byeon2023,
author = {Byeon, Sooin and du Toit-Thompson, Taymin and Gillson, Josef and Gill, Anthony J and Samra, Jaswinder S and Mittal, Anubhav and Sahni, Sumit},
title = {Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6407}
}
EUVIMED